Oral Administration of the Adiponectin Receptor 1 Agonistic Dipeptide Tyr-Pro Prevents Hyperglycemia in Spontaneously Diabetic Torii Rats
Saved in:
Main Authors: | Saya Nakamura, Sumire Asaba, Mitsuru Tanaka, Toshiro Matsui |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2024-12-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.4c09030 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diabetic Cataract in Spontaneously Diabetic Torii Fatty Rats
by: Kasumi Kikuchi, et al.
Published: (2020-01-01) -
Gender Differences in Metabolic Disorders and Related Diseases in Spontaneously Diabetic Torii-Leprfa Rats
by: Takeshi Ohta, et al.
Published: (2014-01-01) -
Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
by: Sheryar Afzal, et al.
Published: (2021-01-01) -
Positron Emission Tomographic Imaging of Copper 64– and Gallium 68–Labeled Chelator Conjugates of the Somatostatin Agonist Tyr-Octreotate
by: Jessie R. Nedrow, et al.
Published: (2014-09-01) -
The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells
by: Sang-Hoon Lee, et al.
Published: (2019-01-01)